Real-world adherence trajectories to direct oral anticoagulants in naive patients with atrial fibrillation in Spain

Autores de FISABIO

• Isabel Hurtado Navarro

  Autor

• Gabriel Sanfelix Gimeno

  Autor

• Francisco Sanchez Saez

  Autor

Autores ajenos a FISABIO

• Leguízamo-Martínez, LM
• Ballarin, ME
• Sabaté, M

Grupos de Investigación

• GRUPO 023. GRUPO DE INVESTIGACIÓN EN SERVICIOS DE SALUD Y FARMACOEPIDEMIOLOGÍA

  Investigador/a Principal

  Gabriel Sanfelix Gimeno

Abstract

Aims This study aimed to identify adherence trajectories and associated factors in atrial fibrillation patients who initiated direct oral anticoagulant (DOAC) therapy, using population-based data from the Catalonia and Valencia regions in Spain during a 2-year follow-up.Methods and Results Group-based trajectory modelling (GBTM) was applied to assess adherence patterns in cohorts comprising 14,641 patients in Catalonia and 13,211 in Valencia. Adherence trajectories were categorised based on prescription data, revealing three main trajectories in Valencia and five in Catalonia. Most patients in Valencia demonstrated high adherence, whereas Catalonia showed more varied patterns, including early, gradual, and late declines. Factors associated with non-adherence included high co-insurance levels, alcohol use, and specific DOACs, such as dabigatran.Conclusion Adherence trajectories differed between the two regions, with three identified in Valencia and five in Catalonia. Shared non-adherence patterns were observed across both cohorts, while Catalonia exhibited additional noncompliance trends. Key factors associated with non-adherence included socio-economic variables, clinical characteristics, and the type of DOAC prescribed. Understanding these patterns is essential for developing targeted intervention strategies to improve adherence and optimise treatment outcomes.

Keywords

• direct oral anticoagulants (DOACs); adherence trajectories; atrial fibrillation (AF); group-based trajectory modeling (GBTM); real-world data analysis